| Name | Title | Contact Details |
|---|
Build Your Proactive Myopia Management Practice With Euclid Orthokeratology!Euclid Systems Corporation is a global leader in Advanced Orthokeratology and Proactive Myopia Management. Proven on millions of eyes around the world, Euclid Ortho-K lenses are designed for the individual patient`s eyes. Thanks to the power of Three Factor Fitting, integrating Euclid orthokeratology into your practice is easy! Simply provide three parameters: RX, K Readings, and HVID. This efficient, empirical process yields a category-leading 87%* first fit success. No trial lenses required. With headquarters in, Virginia, USA, Euclid manufactures all products exclusively in the United States with approval from the U.S. Food & Drug Administration (FDA). The company additionally has offices in Shanghai and Beijing, China, and is leading global efforts in myopia management in children.
landmark is a Fort Worth, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
With iCAD`s technology, cancer has finally met its match. As a global medical technology leader providing innovative cancer detection and therapy solutions, our technologies empower clinicians worldwide with an arsenal of tools to detect cancer and stop it in its tracks – streamlining workflow, improving accuracy, and personalizing results like never before. The ProFound AI Breast Health Suite is the first, best, and only complete, triple-threat solution that combines cancer detection, density assessment, and risk evaluation – all designed to accelerate discovery and improve outcomes. Our leading-edge cancer detection solution, ProFound AI®, is clinically proven to find cancers earlier and with greater accuracy, while slashing reading time for radiologists by more than half. PowerLook® Density Assessment simplifies and standardizes breast density reporting and stratification, offering consistent, accurate and reliable breast density categorization. And the latest addition to our Breast AI Suite, ProFound AI® Risk, is the world`s first clinical decision support tool that provides an accurate short-term breast cancer risk estimation that is truly personalized for each woman, based only on her mammogram. Our Xoft® Axxent® Electronic Brachytherapy (eBx®) System® is transforming the cancer treatment experience by empowering physicians to precisely and effectively target tumors anywhere in the body, anywhere in the world. Using the world`s smallest X-ray source, clinicians can precisely destroy disease while preserving healthy tissue, leaving cancer nowhere to hide.
Companion Medical is a leader in the development of advanced technology to improve diabetes care. Companion`s InPen system is available in the U.S. and is the only FDA-cleared, smart insulin pen paired with an integrated diabetes management app.
BioSphere Medical, Inc. is one of the leading companies in the Healthcare, Pharmaceuticals, & Biotech sector.